Japanese Pharmacopoeial Forum

Revision of the JP is preceded by an announcement in the Japanese Pharmacopoeial Forum (JPF). Public comment is reviewed and if appropriate, accommodated, before the change is made official via the JP or its supplement. The JPF was established in 1992 and is published quarterly in January, April, July, and October. Currently, JPXIII (1996) is official and is updated via supplements approximately every 2 years. 

Any proposal for harmonization must be presented for public comment in each of the pharmacopeial journals, Phar-meuropa (EP), Japanese Pharmacopoeial Forum (JP), and Pharmacopeial Forum (USP). This was accomplished early in 2003 (21-23). Comments were collated and further PDG discussions conducted. Any agreement will be presented again, prior to implementation. The PDG harmonization process can be found as General Information Chapter < 1196 > in USP 27 (24). 

Secretariat of Japanese Pharmacopoeial Forum. Dissolution. J Pharm Forum 2002 11(4) 623-641. 

Stage 3 Pubhcation of fhe draft text in the forum of each pharmacopoeia Pharmeuropa (Ph Eur), Japanese Pharmacopoeial Forum (JP) and Pharmacopoeial Forum (USP) Comments received and consohdated Preparation of a second draft text ( Stage 3 draft )... 

Harmonization proposals do not have official status. The work of the PDG is finished at Stage 5B. The progress of the harmonization projects can and should be verified in the most recent number of the periodicals Pharmacopeial Forum, Japanese Pharmacopoeial Forum, and Pharmeuropa. For standards in force in USP24-NF19, see also the latest supplement or Interim Revision Announcement. 

The Stage 4 draft is published in the forum of each pharmacopeia, with the style adapted to that of the pharmacopeia concerned. In Pharmeuropa and the Japanese Pharmacopoeial Forum, the Stage 4 draft together with the commentary is published in a specific... 

---